Fas (CD95/Apo-1)-mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perforin-deficient mice: A major role for inositol 1,4,5-trisphosphate

Circulation Research

Volumn 82, Issue 4, 1998, Pages 438-450

  Felzen, Bella ^a   Shilkrut, Mark ^a   Less, Hadar ^a   Sarapov, Israel ^b   Maor, Gila ^a   Coleman, Raymond ^a   Robinson, Richard B ^c   Berke, Gideon ^d   Binah, Ofer ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

^c The New York Presbyterian Hospital   (United States)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cytotoxic T lymphocyte; Fas; Inositol trisphosphate; Perforin gene knockout mouse; Ventricular myocyte

Indexed keywords

FAS ANTIGEN; INOSITOL TRISPHOSPHATE; PERFORIN; PHOSPHOLIPASE C;

ADOLESCENT; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CARDIOMYOPATHY; CYTOTOXIC T LYMPHOCYTE; GENE DISRUPTION; GRAFT REJECTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0032498789     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.4.438     Document Type: Article

References (56)

1. Barry WH. Mechanisms of immune-mediated myocyte injury. Circulation. 1994;89:2421-2432.
2. Binah O. Immune effector mechanisms in heart transplant rejection. Cardiol Res. 1994;28:1748-1757.
3. Caves PC, Stinson EB, Billingham ME, Rider AK, Shumway NE. Diagnosis of human. J Heart Transplant. 1988;7:292-297.
4. Chomette G, Auriol M, Cabrol C. Chronic rejection in human heart transplantation: autoimmune myocarditis. Clin Exp Immunol. 1994;96:470-475.
5. Hanawa H, Kodama M, Inomata T, Izumi T, Shibata A, Tsuchida M, Matsumoto Y, Abo T. Anti-αβT receptor antibody prevents the progression of experimental cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg. 1973;66:461-466.
6. Leslie K, Blay R, Haisch C, Lodge A, Weller A, Huber S. Clinical and experimental aspects of viral myocarditis. Clin Microbiol Rev. 1989;2:191-203.
7. Neu N, Ploier B, Ofner C. Cardiac myosin-induced myocarditis: heart autoantibodies are not involved in the induction of the disease. J Immunol. 1990;145:4094-4100.
8. Smith SC, Allen PM. The role of T cells in myosin-induced autoimmune myocarditis. Clin Immunol Immunopathol. 1993;68;100-106.
9. Cabeza-Mackett P, Hontebeyrie-Joskowicz M, Chambo J, Levin M, Laguens RP. Tripanosoma cruzi: aberrant expression of class II major histocompatibility complex molecules in skeletal and heart muscle cells of chronically infected mice. J Mol Cell Cardiol. 1991;72:8-14.
10. Berke G. The Fas-based mechanism of lymphocytotoxicity. Hum Immunol. 1997;54:1-7.
11. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, Anversa P. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest. 1995;73:771-787.
12. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jemkins NA, Nagat S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol. 1992;148:1274-1279.
13. James TN. Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. Circulation. 1994;90:556-573.
14. Narula J, Haider N, Vitmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec W, Khaw BN. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-1189.
15. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996;335:1190-1196.
16. 3 cascade in the damage to guinea pig ventricular myocytes induced by cytotoxic T lymphocytes. Pflugers Arch. 1997;433:721-726.
17. Wagoner LE, Zhao L, Bishop K, Chan S, Xu S, Barry WH. Lysis of adult ventricular myocytes by cells infiltrating rejecting murine cardiac allografts. Circulation. 1996;93:111-119.
18. Binah O, Marom S, Rubinstein I, Robinson RB, Berke G, Hoffman B. Immunological rejection of heart transplant: how lytic cytotoxic T lymphocytes damage guinea-pig ventricular myocytes. Pflugers Arch. 1992;420:172-179.
19. Berke G, Sullivan KA, Amos DB. Rejection of ascites tumor allografts, 1: isolation, characterization and in vitro reactivity of peritoneal lymphoid effector cells from BALB/c mice immune to EL4 leukosis. J Exp Med. 1972;135:1334-1350.
20. Walsh CM, Matloubian M, Liu CG, Ueda R, Kurahara CG, Christensen JL, Huang MY, Young JD, Ahmed R, Clark WR. Immune function in mice lacking the perform gene. Proc Natl Acad Sci U S A. 1994;91:10854-10858.
21. Felzen B, Berke G, Rosen D, Binah O. Mechanisms whereby cytotoxic T lymphocytes damage guinea pig ventricular myocytes. Pflugers. Arch. 1995;427:422-431.
22. + currents in cytotoxic T lymphocytes. Circ Res. 1996;78:253-261.
23. Steinberg SF, Robinson RB, Lieberman HB, Stern DM, Rosen MR. Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. Circ Res. 1991;68:1216-1229.
24. Berrige MJ, Inositol trisphosphate and calcium signaling. Nature. 1993;135:1334-1350.
25. 2+ inflow. Biochem Pharmacol. 1995;49:1373-1379.
26. Smallridge RC, Kiang JG, Gost ID, Fein HG, Galloway RJ. U-73122, an aminosteroid phospholipase-C antagonist, noncompetitively inhibits thyrotropin releasing hormone effects in GH3 rat. Endocrinology. 1992;131:1883-1888.
27. 2+ release in smooth muscle: physiological role of inositol 1,4,5-trisphosphate in pharmacological coupling. J Biol Chem. 1989;264:17997-18004.
28. Rao GH, Fareed J, White JG. Influence of heparins on inositol 1,4,5-trisphosphate induced calcium mobilization in permeabilized human platelets. Biochem Med Metab Biol. 1991;45:171-180.
29. 3 binding site in rat heart sarcoplasmic reticulum. J Mol Cell Cardiol. 1994;26:341-349.
30. 2+ entry: toward a proliferation or simplification? FASEB J. 1992;6:3085-3090.
31. Supattapone S, Worley PF, Barban JM, Snyder SH. Solubilization, purification, and characterization of an inositol trisphosphate receptor. J Biol Chem. 1988;63:1530-1534.
32. Borgatta L, Watras J, Katz AM, Ehrlich BE. Regional differences in calcium-release channels from heart. Proc Natl Acad Sci U S A. 1991;88:2486-2489.
33. 3 receptor concentrations in heart tissues. Clin Exp Pharmacol Physiol. 1994;21:257-260.
34. Moschella MC, Marks AR. Inositol 1,4,5-trisphosphate receptor expression in cardiac myocytes. J Cell Biol. 1993;120:1137-1146.
35. Premack BA, Gardner P. Signal transduction by T-cell receptors: mobilization of Ca and regulation of Ca-dependent effector molecules. Am J Physiol. 1992;263:C1119-C1140.
36. Eckel J, Gerlach-Eskuchen E, Reinauer H. Alpha-adrenoreceptor-mediated increase in cytosolic free calcium in isolated cardiac myocytes. J Mol Cell Cardiol. 1991;23:617-625.
37. 2+ from the SR of skinned cardiac cells. Biophys J. 1986;49:190a. Abstract.
38. 3. Am J Physiol. 1990;58:H610-H615.
39. 2+ release from cardiac sarcoplasmic reticulum. Pflugers Arch. 1991;418:1-6.
40. Anderson KE, Dart AM, Woodcock EA. Inositol phosphate release and metabolism during myocardial ischemia and reperfusion in rat heart. Circ Res. 1995;76:261-268.
41. Steinberg SF, Alter A. Enhanced receptor-dependent inositol phosphate accumulation in hypoxic myocytes. Am J Physiol. 1993;265:H691-H696.
42. 2+ concentrations in guinea pig heart. Jpn Circ J. 1993;57:344-353.
43. 3 release. Circulation. 1995;91:2712-2716.
44. Jacobsen AN, Du XJ, Lambert KA, Dart AM, Woodcock E. Arrhythmogenic action of thrombin during myocardial reperfusion via release of inositol 1,4,5-trisphosphate. Circulation. 1996;93:23-26.
45. Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, Bunting S. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther. 1990;255:756-768.
46. Orrenius S, Nicotera P. The calcium ion and cell death. J Neural Transm. 1994;43:1-11.
47. Lubbe WF, Podzuweit T, Opie LH. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effect of beta-blockers in myocardial infarction and proarrhythmic effect of phosphodiesterase inhibitors. J Am Coll Cardiol. 1992;19:1622-1633.
48. 2+-mediated endonuclease activation. Science. 1988;242:256-259.
49. 2+ level. J Immunol. 1995;154:599-609.
50. 2+ pool and induces apoptosis in human hepatoma cells. Cell Biol Int. 1993;17:969-970.
51. 2+ fluxes. Proc Natl Acad Sci U S A. 1994;91:6569-6573.
52. Rovere P, Clementi E, Ferrarini M, Heltai S, Sciorati C, Sabbadini MG, Rugarli C, Manfredi AA. CD95 engagement releases calcium from intra-cellular stores of long term activated, apoptosis prone gld T cells. J Immunol. 1996;156:4631-4637.
53. Eckel J, Gerlach-Eskuchen E, Reinauer H. Alpha-adrenoreceptor-mediated increase in cytosolic free calcium in isolated cardiac myocytes. J Mol Cell Cardiol. 1991;23:617-625.
54. 3. Am J Physiol. 1990;58:H610-H615.
55. 2+ in permeabilized chick atria. Am J Physiol. 1990;258:H1745-H1752.
56. Jayaraman T, Marks AR. T cells deficient in inositol 1,4,5-triphosphate receptor are resistant to apoptosis. Mol Cell Biol. 1997;17:3005-3012.